ABSTRACT
The title compound, C(14)H(13)NO(2), was obtained by the condensation reaction of o-vanillin and aniline in ethanol. The mol-ecule adopts the phenol-imine tautomeric form and an E conformation with respect to the azomethine C=N bond. The dihedral angle between the aromatic rings is 30.57â (10)°. In the crystal, mol-ecules are linked by inter-molecular C-Hâ¯O hydrogen bonds into zigzag chains parallel to the b axis.
ABSTRACT
In the title compound, [Cd(C(8)H(7)O(3))(2)(C(12)H(8)N(2))(2)]·5H(2)O, the Cd(II) ion is six-coordinated by two carboxylate O atoms of monodentate 2-(4-hy-droxy-phen-yl)acetate ligands and by four N atoms from two chelating 1,10-phenantroline ligands in a distorted trigonal-prismatic geometry. O-Hâ¯O hydrogen bonds between water mol-ecules and the complex mol-ecules result in the formation of a three-dimensional network. Four water mol-ecules act as single acceptors and double donors while the fifth water mol-ecule is involved as a single acceptor and single donor in an O-Hâ¯O inter-action and as a donor in an O-Hâ¯π inter-action.
ABSTRACT
Five transition metal(II) complexes, [ML(2)Cl(2)] 1 approximately 5, were synthesized from the reaction of MCl(2) x nH(2)O (M = Mn, Co, Ni, Cu, Cd) and the Schiff base ligand 2-[(4-methylphenylimino)methyl]-6-methoxyphenol (C(15)H(15)NO(2), L), obtained by condensation of o-vanillin (2-hydroxy-3-methoxybenzaldehyde) with p-toluidine. They were characterized by elemental analysis, molar conductance, FT-IR spectra, thermal analysis. The structure of complex 1 was determined by single-crystal X-ray diffraction. Its crystal structure is of monoclinic system, space group P2(1)/c with a = 9.0111(18) A, b = 11.222(2) A, c =28.130 (6) A, alpha = 90 masculine, beta = 92.29(3) masculine, gamma = 90 masculine, V = 2867.6(10) A(3), Z = 4. The Mn atom is six-coordinate and displays distorted octahedral geometry.The Schiff base ligand and its complexes have been tested in vitro to evaluate their antibacterial activity against bacteria, viz., Escherichia coli, Staphylococcus aureus and Bacillus subtilis. It has been found that the complexes have higher activity than the corresponding free Schiff base ligand against the same bacteria.